| Primary | 
									
											
										
											| Metastases To Bone | 100.0% |  | 
									
											
										
											| Osteonecrosis Of Jaw | 100.0% |  | 
							
						
							| Secondary | 
									
											
										
											| Product Used For Unknown Indication | 37.1% |  
											| Multiple Myeloma | 13.4% |  
											| Osteoporosis | 9.3% |  
											| Breast Cancer Metastatic | 8.2% |  
											| Drug Use For Unknown Indication | 8.2% |  
											| Metastases To Bone | 5.2% |  
											| Prostate Cancer | 4.1% |  
											| Plasma Cell Myeloma | 3.1% |  
											| Chemotherapy | 2.1% |  
											| Diarrhoea | 2.1% |  
											| Lung Neoplasm Malignant | 2.1% |  
											| Breast Neoplasm | 1.0% |  
											| Nausea | 1.0% |  
											| Pain | 1.0% |  
											| Respiratory Disorder | 1.0% |  
											| Vomiting | 1.0% |  | 
									
											
										
											| Osteonecrosis Of Jaw | 25.8% |  
											| Osteonecrosis | 12.9% |  
											| Neuropathy Peripheral | 9.7% |  
											| Renal Cyst | 9.7% |  
											| Infection | 6.5% |  
											| Oroantral Fistula | 3.2% |  
											| Renal Tubular Necrosis | 3.2% |  
											| Skin Exfoliation | 3.2% |  
											| Swelling | 3.2% |  
											| Tooth Extraction | 3.2% |  
											| Tooth Loss | 3.2% |  
											| Upper Limb Fracture | 3.2% |  
											| Urge Incontinence | 3.2% |  
											| Visual Impairment | 3.2% |  
											| Vomiting | 3.2% |  
											| Wound Complication | 3.2% |  | 
							
						
							| Concomitant | 
									
											
										
											| Multiple Myeloma | 22.4% |  
											| Product Used For Unknown Indication | 12.2% |  
											| Drug Use For Unknown Indication | 9.7% |  
											| Prophylaxis | 9.7% |  
											| Hypertension | 7.0% |  
											| Breast Cancer | 4.7% |  
											| Pain | 4.3% |  
											| Plasma Cell Myeloma | 4.3% |  
											| Breast Cancer Metastatic | 4.2% |  
											| Diarrhoea | 3.2% |  
											| Arthritis | 3.0% |  
											| Bone Pain | 2.8% |  
											| Hypoparathyroidism | 2.3% |  
											| Metastases To Bone | 1.8% |  
											| Osteoporosis Prophylaxis | 1.7% |  
											| Antiviral Prophylaxis | 1.3% |  
											| Atrial Fibrillation | 1.3% |  
											| Hypothyroidism | 1.3% |  
											| Supplementation Therapy | 1.3% |  
											| Hypercalcaemia | 1.2% |  | 
									
											
										
											| Thrombocytopenia | 19.5% |  
											| Renal Failure Acute | 7.8% |  
											| Septic Shock | 7.8% |  
											| Ventricular Fibrillation | 6.5% |  
											| Intestinal Obstruction | 5.2% |  
											| Multiple Myeloma | 5.2% |  
											| Pain | 5.2% |  
											| Urinary Tract Infection | 5.2% |  
											| Pyrexia | 3.9% |  
											| Renal Failure | 3.9% |  
											| Renal Impairment | 3.9% |  
											| Subdural Haematoma | 3.9% |  
											| Tachycardia Paroxysmal | 3.9% |  
											| Dermatitis Psoriasiform | 2.6% |  
											| Dyspnoea | 2.6% |  
											| Electrolyte Imbalance | 2.6% |  
											| Femoral Neck Fracture | 2.6% |  
											| Gastritis | 2.6% |  
											| Hyponatraemia | 2.6% |  
											| Localised Infection | 2.6% |  |